Thrombocytopenia and platelet hypoaggregation induced by Bothrops asper snake venom. Toxins involved and their contribution to metalloproteinase-induced pulmonary hemorrhage

Thrombosis and Haemostasis

Volumn 94, Issue 1, 2005, Pages 123-131

  Rucavado, Alexandra ^a   Soto, Mónica ^a   Escalante, Teresa ^a   Loría, Gilbert D ^a   Arni, Raghuvir ^b   Gutiérrez, José María ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Coagulopathy; Defibrin(ogen)ation; Hypoaggregation; Snake venom; Thrombocytopenia

Indexed keywords

ALPHA 2 MACROGLOBULIN; BATIMASTAT; D DIMER; FIBRINOGEN DEGRADATION PRODUCT; LECTIN; METALLOPROTEINASE; PROCOAGULANT; SERINE PROTEINASE; SNAKE VENOM; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; BLOOD CLOTTING PARAMETERS; CONTROLLED STUDY; EX VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SNAKE; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA;

ALPHA-MACROGLOBULINS; ANIMALS; BLEEDING TIME; BLOOD PLATELETS; BOTHROPS; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMORRHAGE; HUMANS; LUNG; METALLOENDOPEPTIDASES; METALLOPROTEASES; MICE; PLATELET AGGREGATION; SNAKE VENOMS; THROMBOCYTOPENIA; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 22144451490     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-02-0112     Document Type: Article

References (50)

1. Warrell DA. Snakebites in Central and South America: epidemiology, clinical features, and clinical management. In: The Venomous Reptiles in the Western Hemisphere, vol II Campbell JA, Lamar WW, Comstock Ithaca 2004; 709-61.
2. Kamiguti AS, Cardoso JLC, Theakston RDG et al. Coagulopathy and haemorrhage in human victims of Bothrops jararaca envenoming in Brazil. Toxicon 1991; 29: 961-72.
3. Otero R, Tobón GS, Gómez LF et al. Accidente ofidico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989-febrero de 1990). Acta Méd Colomb 1992; 17: 229-49.
4. Cardoso JLC, Fan HW, Franca FOS et al. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Q J Med 1993; 86: 315-25.
5. Fan HW, Cardoso JL. Clinical toxicology of snake bites in South America. In: Handbook of Clinical Toxicology of Animal Venoms and Poisons. Meier J, White J, CRC Press, Florida 1995; 667-88.
6. Gutiérrez JM. Clinical toxicology of snake bite in Central America. In: Handbook of Clinical Toxicology of Animal Venoms and Poisons. Meier J, White J, CRC Press, Florida 1995; 645-65.
7. Kini RM, Evans HJ. Effects of snake venom proteins on blood platelets. Toxicon 1990; 28: 1387-422.
8. Markland FS. Snake venoms and the hemostatic system. Toxicon 1998; 36: 1749-800.
9. Aragón-Ortiz F, Gubensek F. Characterization of thrombin-like proteinase from Bothrops asper venom. In: Toxins: Animal, Plant and Microbial, Rosenberg P, Pergamon Press, Oxford 1978; 107-11.
10. Loría GD, Rucavado A, Kamiguti AS et al. Characterization of 'basparin A', a prothrombin-activating metalloproteinase, from the venom of the snake Bothrops asper that inhibits platelet aggregation and induces defibrination and thrombosis. Arch Biochem Biophys 2003; 418: 13-24.
11. Rucavado A, Escalante T, Gutiérrez JM. Effect of the metalloproteinase inhibitor batimastat in the systemic toxicity induced by Bothrops asper snake venom: understanding the role of metalloproteinases in envenomation. Toxicon 2004; 43: 417-24.
12. Peña-Chavarría A, Villarejos VM, Zomer M. Clinical importance of prothrombin time determination in snake-venom poisoning. Am J Trop Med Hyg 1970; 19: 342-4.
13. Barrantes A, Solís V, Bolaños R. Alteración de los mecanismos de la coagulación en el envenenamiento por Bothrops asper (terciopelo). Toxicon 1985; 23: 399-407.
14. Sano-Martins IS, Santoro ML, Castro SCB et al. Platelet aggregation in patients bitten by the Brazilian snake Bothrops jararaca. Thromb Res 1997; 87: 183-95.
15. Rucavado A, Soto M, Kamiguti AS et al. Characterization of aspercetin, a platelet aggregating component from the venom of the snake Bothrops asper which induces thrombocytopenia and potentiates metalloproteinase-induced hemorrhage. Thromb Haemost 2001; 85: 710-5.
16. Pinto A, Angulo Y, Jiménez R et al. Isolation of bothrasperin, a disintegrin with potent platelet aggregation inhibitory activity, from the venom of the snake Bothrops asper. Rev Biol Trop 2003; 51: 253-9.
17. Paine MJI, Desmon HP, Theakston RDG et al. Purification, cloning and molecular characterization of a high molecular weight hemorrhagic metalloproteinase, jararhagin, from Bothrops jararaca venom. J Biol Chem 1992; 267: 22869-76.
18. Gutiérrez JM, Romero M, Díaz C et al. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 1995; 33: 19-29.
19. Watanabe L, Shannon JD, Valente RH et al. Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities. Prot Sci 2003; 12: 2273-81.
20. Bortoleto RK, Murakami MT, Watanabe L et al. Purification, characterization and crystallization of Jararacussin-I, a fibrinogen-clotting enzyme isolated from the venom of Bothrops jararacussu. Toxicon 2002; 40: 1307-12.
21. Kaiser II, Gutiérrez JM, Plummer D et al. The amino acid sequence of a myotoxic phospholipase from the venom of Bothrops asper. Arch Biochem Biophys 1990; 278: 319-25.
22. Franceschi A, Rucavado A, Mora N et al. Purification and characterization of BaH4, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Toxicon 2000; 38; 63-77.
23. Tijssen P. Practice and Theory of Enzyme Immunoassays. Amsterdam, Elsevier, 1985.
24. Gené JA, Roy A, Rojas G et al. Comparative study on coagulant, defibrinating, fibrinolytic and fibrinogenolytic activities of Costa Rican crotaline snake venoms and their neutralization by a polyvalent antivenom. Toxicon 1989; 27: 841-8.
25. Denis C, Methia N, Frenette PS et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524-9.
26. Moura da Silva AM, Línica A, Della-Casa MS et al. Jararhagin ECD-disintegrin domain: expression in Escherichia coli and inhibition of the platelet-collagen interaction. Arch Biochem Biophys 1999; 369: 295-301.
27. 2-macroglobulin and mouse serum and does not induce systemic hemorrhage or coagulopathy. Toxicon 2004; 43: 213-7.
28. 1 integrin by the snake venom metalloproteinase jararhagin. Biochem J 1996; 320: 635-41.
29. Escalante T, Núñez J, Moura da Silva AM et al. Pulmonary hemorrhage induced by jararhagin, a metalloproteinase from Bothrops jararaca snake venom. Toxicol Appl Pharmacol 2003; 193: 17-28.
30. Brinkhous KM, Barnes D, Potter JY et al. Von Willebrand syndrome induced by a Bothrops venom factor: Bioassay for venom coagglutinin. Pro Natl Acad Sci USA 1981; 78: 3230-4.
31. Sanders WE, Read MS, Reddick RL et al. Thrombotic thrombocytopenia with von Willebrand factor deficiency induced by botrocetin. An animal model. Lab Invest 1988; 59: 443-52.
32. Sen U, Vasudevan S, Subbarao G et al. Crystal structure of the von Willebrand factor modulator botrocetin. Biochemistry 2001; 40: 345-52.
33. Fukuda K, Doggett T, Laurenzi IJ et al. The snake venom protein botrocetin acts as a biological brace to promote dysfunctional platelet aggregation. Nature Struc Mol Biol 2005; 12: 152-9.
34. Slade CL, Andes WA, Mason AD. Platelet aggregation following defibrination with ancrod. Thromb Haemost 1976; 36: 424-9.
35. Ownby CL, Bjarnason JB, Tu AT. Hemorrhagic toxins from rattlesnake (Crotalus atrox) venom. Pathogenesis of hemorrhage induced by three purified toxins. Am J Pathol 1978; 93: 201-18.
36. Ownby CL, Geren CR. Pathogenesis of hemorrhage induced by hemorrhagic proteinase IV from timber rattlesnake (Crotalus horridus horridus) venom. Toxicon 1987; 25: 517-26
37. Moreira L, Borkow G, Ovadia M et al. Pathological changes induced by BaH1, a hemorrhagic proteinase isolated from Bothrops asper (terciopelo) snake venom, on mouse capillary blood vessels. Toxicon 1994; 32: 977-87.
38. Kamiguti AS, Theakston RDG, Desmond H et al. Systemic haemorrhage in rats induced by a haemorrhagic fraction from Bothrops jararaca venom. Toxicon 1991; 29: 1097-105.
39. Konstam MA, Brockway BA, Aronovitz MJ et al. Kinetics of pulmonary platelet deposition and clearance during thrombin-induced microembolism in rabbits. Exp Lung Res 1989; 15: 867-79.
40. Santoro ML, Sano-Martins IS. Platelet dysfunction during Bothrops jararaca snake envenomation in rabbits. Thromb Haemost 2004; 92: 369-83.
41. Chang MC, Huang TF. The antiplatelet activity of ancrod on administration to rabbits. J Lab Clin Med 1995; 125: 508-16.
42. Santoro ML, Sano-Martins IS, Chamone DAF. In vivo platelet activation induced by Bothrops jararaca venom in rabbits. Platelets 1994; 5: 162-70.
43. Thorsen LI, Brosstad F, Gogstad G et al. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor. Thromb Res 1986; 44: 611-23.
44. Pasqua JJ, Pizzo SV. The role of ligand-ligand interactions in competition by fibrinogen and fibrin degradation products for fibrinogen binding to human platelets. Biochim Biophys Acta 1983; 757: 282-7.
45. Chen CS, Chou SH, Thiagarajan P. Fibrin(ogen) peptide Bβ 15-42 inhibits platelet aggregation and fibrinogen binding to activated platelets. Biochemistry 1988; 27: 6121-6.
46. Rodrigues VM, Soares AM, Andriao-Escarso SH et al. Pathological alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi snake venom. Biochimie 2001; 83: 471-9.
47. Bjarnason JB, Fox JW. Hemorhagic metalloproteinases from snake venoms. Pharmac Ther 1994; 62: 325-72.
48. Baramova EN, Shannon JD, Bjarnason JB et al. Interaction of hemorrhagic metalloproteinases with human α2-macroglobulin. Biochemistry 1990; 29: 1069-74.
49. Kamiguti AS, Desmond HP, Theakston RDG et al. Ineffectiveness of the inhibition of the main hemorrhagic metalloproteinase from Bothrops jararaca venom by its only plasma inhibitor, α2-macroglobulin. Biochim Biophys Acta 1994; 1200: 307-4.
50. Estevao-Costa, MI, Diniz CR, Magalhaes A et al. Action of metalloproteinases mutalysin I and II on several components of the hemostatic and fibrinolytic systems. Thromb Res 2000; 99: 363-76.